SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-24-004181
Filing Date
2024-07-26
Accepted
2024-07-26 16:30:11
Documents
35
Period of Report
2024-07-26
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_072624.htm   iXBRL 8-K 23283
2 EXHIBIT 99.1 exh_991.htm EX-99.1 37978
7 GRAPHIC exh991_01.jpg GRAPHIC 37554
8 GRAPHIC exh991_02.jpg GRAPHIC 147088
9 GRAPHIC exh991_03.jpg GRAPHIC 71179
10 GRAPHIC exh991_04.jpg GRAPHIC 110847
11 GRAPHIC exh991_05.jpg GRAPHIC 107861
12 GRAPHIC exh991_06.jpg GRAPHIC 106417
13 GRAPHIC exh991_07.jpg GRAPHIC 124402
14 GRAPHIC exh991_08.jpg GRAPHIC 113297
15 GRAPHIC exh991_09.jpg GRAPHIC 124911
16 GRAPHIC exh991_10.jpg GRAPHIC 89194
17 GRAPHIC exh991_11.jpg GRAPHIC 73403
18 GRAPHIC exh991_12.jpg GRAPHIC 39449
19 GRAPHIC exh991_13.jpg GRAPHIC 92400
20 GRAPHIC exh991_14.jpg GRAPHIC 129300
21 GRAPHIC exh991_15.jpg GRAPHIC 110021
22 GRAPHIC exh991_16.jpg GRAPHIC 113667
23 GRAPHIC exh991_17.jpg GRAPHIC 77285
24 GRAPHIC exh991_18.jpg GRAPHIC 133304
25 GRAPHIC exh991_19.jpg GRAPHIC 95953
26 GRAPHIC exh991_20.jpg GRAPHIC 13192
  Complete submission text file 0001171843-24-004181.txt   2921621

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE apto-20240726.xsd EX-101.SCH 3275
4 XBRL DEFINITION FILE apto-20240726_def.xml EX-101.DEF 26200
5 XBRL LABEL FILE apto-20240726_lab.xml EX-101.LAB 35952
6 XBRL PRESENTATION FILE apto-20240726_pre.xml EX-101.PRE 24858
37 EXTRACTED XBRL INSTANCE DOCUMENT f8k_072624_htm.xml XML 5913
Mailing Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6
Business Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 241147346
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)